Skip to main content
. 2023 Feb 25;21(1):e132647. doi: 10.5812/ijpr-132647

Table 1. Baseline Demographic and Laboratory Characteristics a.

Variables CBD/Δ9-THC (10:1) Group (n = 24) Placebo Group (n = 22) P-Value
Age, y 55.7 ± 1.7 53.2 ± 1.3 0.26
Gender (males) 6 (33.34) 5 (27.8) 0.99
Body mass index, kg/m 2 30.7 ± 0.8 31.2 ± 0.7 0.64
Current smoker 3 (16.67) 2 (11.2) 0.99
Microvascular complications 1 (5.6) 1 (5.6) 1
Hypertension 0 (0) 1 (5.6) 0.99
Fasting glucose, mg/dL 144.9 ± 17.9 139.2 ± 16.5 0.27
Cholesterol, mg/dL 159.2 ± 10.2 145.8 ± 9.9 0.35
Triglyceride, mg/dL 169.8 ± 21.4 134.2 ± 13.7 0.16
HDL-cholesterol, mg/dL 41.06 ± 1.3 42.3 ± 1.6 0.57
LDL-cholesterol, mg/dL 98.53 ± 8.2 86.9 ± 8.8 0.34
Creatinine, mg/dL 0.96 ± 0.08 0.92 ± 0.06 0.2
Hb A1C , % 7.94 ± 0.34 7.41 ± 0.16 0.18
Insulin baseline (mIU/L) 26.27 ± 3.60 24.2 ± 3.70 0.08
HOMA2-IR 3.68 ± 0.65 3.36 ± 0.66 0.10
HOMA2β 91.2 ± 9.4 92.5 ± 9.3 0.80

a Values are expressed as No. (%) or mean ± SD.